methimazole NDC 67046-1652

NDC codes

FDA NDC Directory

Product NDC (as listed)67046-1652Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67046-1652Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
67046-1652-3	67046165203	30 TABLET in 1 BLISTER PACK (67046-1652-3)Marketed from Jan 23, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): methimazole
Generic name (nonproprietary): methimazole
Active ingredients: Methimazole — 10 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Coupler LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218830
Marketing start: Jan 23, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Thyroid Hormone Synthesis Inhibitors (Mechanism)
Identifiers: Product ID 67046-1652_490f163b-b151-d74b-e063-6394a90ad438SPL ID 490f163b-b151-d74b-e063-6394a90ad438SPL set ID 490f168f-c703-5497-e063-6294a90ade87RxCUI 197941UNII 554Z48XN5E
Pharmacologic class: Thyroid Hormone Synthesis Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N467046165203 followed by a unit qualifier and the quantity

Package 67046-1652-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 23, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 218830

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218830
Product	Strength	Form · route	Labeler	Product NDC
methimazole	Methimazole 5 mg/1	TabletOral	Coupler LLC	67046-1651
methimazole	Methimazole 5 mg/1	TabletOral	SQUARE PHARMACEUTICALS PLC.	76483-082
methimazole	Methimazole 10 mg/1	TabletOral	SQUARE PHARMACEUTICALS PLC.	76483-083
methimazole	Methimazole 5 mg/1	TabletOral	Viona Pharmaceuticals Inc.	72578-212
methimazole	Methimazole 10 mg/1	TabletOral	Viona Pharmaceuticals Inc.	72578-213